Merit Medical Systems Profit Margin 2006-2019 | MMSI

Current and historical gross margin, operating margin and net profit margin for Merit Medical Systems (MMSI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Merit Medical Systems net profit margin as of September 30, 2019 is 1.94%.
Merit Medical Systems Annual Profit Margins
Merit Medical Systems Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.609B $0.883B
Merit Medical Systems, Inc. set out to build the world's most customer-focused healthcare company by understanding customers' needs, and innovating and delivering a diverse range of products that improve the lives of people, families, and communities throughout the world. Merit's primary products consist of inflation devices used in angioplasty and stent placement; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; diagnostic and hydrophilic products used to manage and monitor the administration of contrast media and other fluid solutions; thrombolytic catheters and fluid dispensing systems; and embolotherapeutic products for the treatment of uterine fibroids, hypervascularised tumours, and arteriovenous malformations; and procedural trays, packs, and kits.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $70.506B 22.32
McKesson (MCK) United States $25.635B 10.16
Align Technology (ALGN) United States $21.730B 59.55
AmerisourceBergen (ABC) United States $18.171B 12.46
Laboratory Of America Holdings (LH) United States $16.670B 15.65
Cardinal Health (CAH) United States $16.049B 10.43
Straumann Holding AG (SAUHF) Switzerland $15.257B 0.00
Cooper (COO) United States $15.229B 24.87
DENTSPLY SIRONA (XRAY) United States $12.911B 25.24
West Pharmaceutical Services (WST) United States $10.911B 46.82
Henry Schein (HSIC) United States $10.187B 18.97
CONMED (CNMD) United States $3.236B 45.97
Patterson (PDCO) United States $2.250B 16.67
STAAR Surgical (STAA) United States $1.662B 86.79
Atrion (ATRI) United States $1.310B 36.09
Antares Pharma (ATRS) United States $0.798B 489.00
Invacare (IVC) United States $0.310B 0.00
Lifevantage (LFVN) United States $0.213B 23.46
Milestone Scientific (MLSS) United States $0.075B 0.00
Pro-Dex (PDEX) United States $0.063B 17.07
Retractable Technologies (RVP) United States $0.043B 66.00
Endologix (ELGX) United States $0.042B 0.00
Biolase (BIOL) United States $0.016B 0.00